Cargando…
Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
The main issue concerning localized prostate cancers is the lack of a suitable marker which could help patients’ stratification at diagnosis and distinguish those with a benign disease from patients with a more aggressive cancer. Circulating Tumor Cells (CTC) are spread in the blood by invasive tumo...
Autores principales: | Broncy, Lucile, Paterlini-Bréchot, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678597/ https://www.ncbi.nlm.nih.gov/pubmed/31277346 http://dx.doi.org/10.3390/cells8070676 |
Ejemplares similares
-
Circulating Tumor Cells for the Management of Renal Cell Carcinoma
por: Broncy, Lucile, et al.
Publicado: (2018) -
Circulating Tumor Cells: Who is the Killer?
por: Paterlini-Bréchot, Patrizia
Publicado: (2014) -
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion
por: Laget, Sophie, et al.
Publicado: (2017) -
Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma
por: Broncy, Lucile, et al.
Publicado: (2018) -
Predictive Value of Circulating Tumor Cells Detected by ISET(®) in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy
por: Garrido Castillo, Laura Nalleli, et al.
Publicado: (2022)